日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

C5a enhances inflammation and chemotaxis of γδ T cells in malignant pleural effusion

C5a 增强恶性胸腔积液中 γδT 细胞的炎症和趋化作用

Shuanglinzi Deng, Yuanyuan Jiang, Lisha Luo, Huan Tang, Xinyue Hu, Chendong Wu, Jiale Tang, Huan Ge, Xiaoxiao Gong, Runjin Cai, Guo Wang, Xiaozhao Li, Juntao Feng

TQB2450 in patients with advanced malignant tumors: results from a phase I dose-escalation and expansion study

TQB2450治疗晚期恶性肿瘤患者:一项I期剂量递增和扩展研究的结果

Xue, Junli; Xue, Liqiong; Tang, Wenbo; Ge, Xiaoxiao; Zhao, Wei; Li, Qun; Peng, Wei; Dai, Congqi; Guo, Ye; Li, Jin

First-in-human study of GFH018, a small molecule inhibitor of transforming growth factor-β receptor I inhibitor, in patients with advanced solid tumors

GFH018(一种转化生长因子-β受体I小分子抑制剂)在晚期实体瘤患者中的首次人体研究

Guo, Ye; Wang, Zishu; Zhou, Huan; Pan, Hongming; Han, Weidong; Deng, Yanhong; Li, Qun; Xue, Junli; Ge, Xiaoxiao; Wang, Shuang; Wang, Jing; Zhang, Yue; Zhao, Congqiao; Zhu, Huaqiang; Wang, Yu; Shen, Haige; Liu, Dong; Li, Jin

Phase I trial of KN046, a novel bispecific antibody targeting PD-L1 and CTLA-4 in patients with advanced solid tumors

KN046是一种新型双特异性抗体,靶向PD-L1和CTLA-4,用于治疗晚期实体瘤患者,目前正在进行I期临床试验。

Ma, Yuxiang; Xue, Jinhui; Zhao, Yuanyuan; Zhang, Yang; Huang, Yan; Yang, Yunpeng; Fang, Wenfeng; Guo, Ye; Li, Qun; Ge, Xiaoxiao; Sun, Jie; Zhang, Bangyong; Zhang, Yuhan; Xiao, Jinyuan; Zhang, Li; Zhao, Hongyun

Nogo-B inhibition restricts ulcerative colitis via inhibiting p68/miR-155 signaling pathway

Nogo-B 抑制剂通过抑制 p68/miR-155 信号通路抑制溃疡性结肠炎

Juan Zheng, Shengnan Wang, Tingting Zhang, Huaxin Li, Mengmeng Zhu, Xiaoning Wei, Yu Ge, Xiaoxiao Yang, Shuang Zhang, Hongmei Xu, Yajun Duan, Lipei Liu, Yuanli Chen

Next-generation sequencing identifies CDKN2A alterations as prognostic biomarkers in recurrent or metastatic head and neck squamous cell carcinoma predominantly receiving immune checkpoint inhibitors

新一代测序技术发现,CDKN2A 改变可作为复发性或转移性头颈部鳞状细胞癌的预后生物标志物,这些患者主要接受免疫检查点抑制剂治疗。

Xue, Liqiong; Tang, Wenbo; Zhou, Jiuli; Xue, Junli; Li, Qun; Ge, Xiaoxiao; Lin, Fengjuan; Zhao, Wei; Guo, Ye

Immune-related adverse events and outcomes among pan-cancer patients receiving immune checkpoint inhibitors: A monocentric real-world observational study

接受免疫检查点抑制剂治疗的泛癌患者的免疫相关不良事件和结局:一项单中心真实世界观察性研究

Ge, Xiaoxiao; Jiang, Weiping; Li, Hongqing; Wu, Yanxu; Li, Xiangyang; Cui, Shaohua

[A Real-world Study on the Incidence and Outcome of Immune-related Adverse Events in Lung Cancer Patients]

【肺癌患者免疫相关不良事件发生率及结局的真实世界研究】

Cui, Shaohua; Ge, Xiaoxiao; Li, Xiangyang

The role and possible mechanism of the long noncoding RNA LINC01260 in nonalcoholic fatty liver disease.

长链非编码RNA LINC01260在非酒精性脂肪肝疾病中的作用及可能机制

Ge Xiaoxiao, Sun Tao, Zhang Yanmei, Li Yongqing, Gao Peng, Zhang Dantong, Zhang Bingyang, Wang Peijun, Ma Wanshan, Lu Sumei

Safety, tolerability, and pharmacokinetics/pharmacodynamics of JMT103 in patients with bone metastases from solid tumors

JMT103在实体瘤骨转移患者中的安全性、耐受性和药代动力学/药效学研究

Liang, Xu; Xue, Junli; Ge, Xiaoxiao; Li, Jin; Li, Huiping; Xue, Liqiong; Di, Lijun; Tang, Wenbo; Song, Guohong; Li, Qun; Jiang, Hanfang; Zhao, Wei; Lin, Fengjuan; Shao, Bin; Yang, Xiugao; Wu, Zhufeng; Zhang, Tianyi; Wang, Chenchen; Guo, Ye